Ocular Adnexal Lymphomas: Single-Center Experience.
Articles > Article · 2015
Authors: Melda Comert Ozkan, Melis PALAMAR ONAY, Murat TOMBULOĞLU, Mine HEKİMGİL, Nazan ÖZSAN, Güray SAYDAM, Fahri ŞAHİN
Clinical lymphoma, myeloma & leukemia, Journal Indexed in SCI Expanded, International, 2015, vol 15, pp S158-S160
DOI: 10.1016/j.clml.2015.02.015
Summary
Ocular adnexal lymphoma (OAL) is a rare manifestation of non-Hodgkin lymphoma consisting of the tissues and structures surrounding the eye that include the conjunctiva, eyelids, lacrimal gland, and orbital soft tissues. OAL comprise 1% to 2% of all non-Hodgkin lymphomas and about 8% of the extranodal lymphomas; however, the incidence of OAL has increased by approximately 6% annually in last 2 decades, and OAL now represents the majority of orbital malignancies. There are no uniform treatment guidelines for OAL. Because of high local and extraorbital recurrence rates, appropriate local, systemic, or combined treatment must be applied. (C) 2015 Elsevier Inc. All rights reserved.